Skip to main content

Breadcrumb

  1. Home

Behavioral Health

Bipolar antimanic agent

This measure identifies the percentage of patients with newly diagnosed bipolar disorder who have received at least 1 prescription for a mood-stabilizing agent during the measurement year.

CBE ID
0580

Bipolar Disorder: Assessment for diabetes

Percentage of patients treated for bipolar disorder who are assessed for diabetes within 16 weeks after initiating treatment with an atypical antipsychotic agent.

CBE ID
0003

Bipolar Disorder: Level-of-function evaluation

Percentage of patients treated for bipolar disorder with evidence of level-of-function evaluation at the time of the initial assessment and again within 12 weeks of initiating treatment

CBE ID
0112

Child and Adolescent Major Depressive Disorder: Diagnostic Evaluation

Percentage of patients aged 6 through 17 years with a diagnosis of major depressive disorder with documented evidence that they met the DSM-IV criteria [at least 5 elements with symptom duration of two weeks or longer, including 1) depressed mood (can be irritable mood in children and adolescents) or 2) loss of interest or pleasure] during the visit in which the new diagnosis or recurrent episode was identified

CBE ID
1364

Depression Assessment Conducted

Percent of patients who were screened for depression (using a standardized depression screening tool) at start or resumption of home health care

CBE ID
0518